The age factor in bilateral hydrocele diagnosis secondary to a primitive testis lymphoma : case report, diagnosis and therapy

Primitive NHL represents 9% of testis tumours and the 85% is diagnosed in patient older thant 60 years old. Usually pain and a testis mass are the main manifestations. The Authors report the case of a 82 years-old man with bilateral hydrocele causing severe alteration in the deambulation. The cytology did not show blood cells or neoplastic cell in the FNAB. The US showed a complete modification in the testis. The patient underwent to surgery intervention of vaginalis tunic eversion and resection with the aim of control the symptoms. The histology on multiple biopsy of testis and epidydims bilaterally showed a large B-cell lymphoma. The patient was treated with 6 chemotheray cycles (Rituximab, Vincristine, Cyclophosphamide, Prednisone). Bilateral hydrocele is a rare clinical presentation of testis NHL. In this patient, blood and neoplastic cell absence in the cytology made difficult the differential diagnosis between inflammatory pathology and neoplasia. Hystopathologic study and immunologic pattern can make a certain diagnosis.

Medienart:

E-Artikel

Erscheinungsjahr:

2012

Erschienen:

2012

Enthalten in:

Zur Gesamtaufnahme - volume:163

Enthalten in:

La Clinica terapeutica - 163(2012), 1 vom: 15., Seite e23-6

Sprache:

Italienisch

Weiterer Titel:

Il fattore età nella diagnosi clinica di idrocele bilaterale da linfoma primitivo del testicolo: caso clinico e considerazioni diagnostico-terapeutiche

Beteiligte Personen:

Spaziani, E [VerfasserIn]
Di Filippo, A [VerfasserIn]
Picchio, M [VerfasserIn]
De Angelis, F [VerfasserIn]
Corazza, S [VerfasserIn]
Narilli, F [VerfasserIn]
Cimino, G [VerfasserIn]

Themen:

4F4X42SYQ6
5J49Q6B70F
80168379AG
8N3DW7272P
Antibodies, Monoclonal, Murine-Derived
Case Reports
Cyclophosphamide
Doxorubicin
Journal Article
Prednisone
Rituximab
VB0R961HZT
Vincristine

Anmerkungen:

Date Completed 22.06.2012

Date Revised 25.11.2016

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM215688422